Fig. 2
From: Novel target and treatment agents for natural killer/T-cell lymphoma
An overview of the six hallmark characteristics in the pathogenesis of NKTCL and targeted therapies. NKTCL: natural killer/T-cell lymphoma, PD-L1: programmed cell death ligand 1, MLL2: mixed lineage leukemia 2, BCOR: BCL-6 corepressor, JAK/STAT: Janus-associated kinase/signal transducer and activator of transcription, PDGFR: platelet-derived growth factor receptor, PI3K: phosphatidylinositol 3-kinase, NF-κB: nuclear factor κB, LMP1: latent membrane protein 1